Adam Savitz's Insider Trades & SAST Disclosures

Adam Savitz's most recent trade in Alto Neuroscience Inc. was a trade of 76,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 5, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alto Neuroscience Inc.
Adam Savitz CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2025 76,000 76,000 - - Employee Stock Option (Right to Buy)
Alto Neuroscience Inc.
Adam Savitz CHIEF MEDICAL OFFICER Purchase of securities on an exchange or from another person at price $ 12.53 per share. 09 Jul 2024 10,681 35,532 - 12.5 133,833 Common Stock
Alto Neuroscience Inc.
Adam Savitz CHIEF MEDICAL OFFICER Purchase of securities on an exchange or from another person at price $ 13.22 per share. 09 Jul 2024 2,931 39,851 - 13.2 38,748 Common Stock
Alto Neuroscience Inc.
Adam Savitz CHIEF MEDICAL OFFICER Purchase of securities on an exchange or from another person at price $ 13.15 per share. 09 Jul 2024 1,388 36,920 - 13.1 18,252 Common Stock
Alto Neuroscience Inc.
Adam Savitz CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 73,000 73,000 - - Employee Stock Option (Right to Buy)
Alto Neuroscience Inc.
Adam Savitz CHIEF MEDICAL OFFICER Purchase of securities on an exchange or from another person at price $ 16.00 per share. 06 Feb 2024 17,000 24,851 - 16 272,000 Common Stock
Alto Neuroscience Inc.
Adam Savitz CHIEF MEDICAL OFFICER 06 Feb 2024 16,666 0 - - Series B Preferred Stock
Alto Neuroscience Inc.
Adam Savitz CHIEF MEDICAL OFFICER 06 Feb 2024 7,851 7,851 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades